Integrating Molecular Networking and Biological Assays To Target the Isolation of a Cytotoxic Cyclic Octapeptide, Samoamide A, from an American Samoan Marine Cyanobacterium
- PMID: 28055219
- PMCID: PMC5758054
- DOI: 10.1021/acs.jnatprod.6b00907
Integrating Molecular Networking and Biological Assays To Target the Isolation of a Cytotoxic Cyclic Octapeptide, Samoamide A, from an American Samoan Marine Cyanobacterium
Abstract
Integrating LC-MS/MS molecular networking and bioassay-guided fractionation enabled the targeted isolation of a new and bioactive cyclic octapeptide, samoamide A (1), from a sample of cf. Symploca sp. collected in American Samoa. The structure of 1 was established by detailed 1D and 2D NMR experiments, HRESIMS data, and chemical degradation/chromatographic (e.g., Marfey's analysis) studies. Pure compound 1 was shown to have in vitro cytotoxic activity against several human cancer cell lines in both traditional cell culture and zone inhibition bioassays. Although there was no particular selectivity between the cell lines tested for samoamide A, the most potent activity was observed against H460 human non-small-cell lung cancer cells (IC50 = 1.1 μM). Molecular modeling studies suggested that one possible mechanism of action for 1 is the inhibition of the enzyme dipeptidyl peptidase (CD26, DPP4) at a reported allosteric binding site, which could lead to many downstream pharmacological effects. However, this interaction was moderate when tested in vitro at up to 10 μM and only resulted in about 16% peptidase inhibition. Combining bioassay screening with the cheminformatics strategy of LC-MS/MS molecular networking as a discovery tool expedited the targeted isolation of a natural product possessing both a novel chemical structure and a desired biological activity.
Conflict of interest statement
Figures
Similar articles
-
Total synthesis and cyclization strategy of samoamide A, a cytotoxic cyclic octapeptide rich in proline and phenlalanine isolated from marine cyanobacterium.J Asian Nat Prod Res. 2019 Feb;21(2):171-177. doi: 10.1080/10286020.2018.1450391. Epub 2018 Apr 19. J Asian Nat Prod Res. 2019. PMID: 29671350
-
Benderamide A, a Cyclic Depsipeptide from a Singapore Collection of Marine Cyanobacterium cf. Lyngbya sp.Mar Drugs. 2018 Oct 26;16(11):409. doi: 10.3390/md16110409. Mar Drugs. 2018. PMID: 30373109 Free PMC article.
-
Venturamides A and B: antimalarial constituents of the panamanian marine Cyanobacterium Oscillatoria sp.J Nat Prod. 2007 Mar;70(3):397-401. doi: 10.1021/np0605790. Epub 2007 Mar 1. J Nat Prod. 2007. PMID: 17328572
-
Tutuilamides A-C: Vinyl-Chloride-Containing Cyclodepsipeptides from Marine Cyanobacteria with Potent Elastase Inhibitory Properties.ACS Chem Biol. 2020 Mar 20;15(3):751-757. doi: 10.1021/acschembio.9b00992. Epub 2020 Jan 28. ACS Chem Biol. 2020. PMID: 31935054 Free PMC article.
-
Molecular Networking-Based Screening Led to the Discovery of a Cyclic Heptadepsipeptide from an Endolichenic Xylaria sp.J Nat Prod. 2022 Apr 22;85(4):972-979. doi: 10.1021/acs.jnatprod.1c01108. Epub 2022 Apr 6. J Nat Prod. 2022. PMID: 35385664 Review.
Cited by
-
Marine Cyanobacteria: A Source of Lead Compounds and their Clinically-Relevant Molecular Targets.Molecules. 2020 May 8;25(9):2197. doi: 10.3390/molecules25092197. Molecules. 2020. PMID: 32397127 Free PMC article. Review.
-
Application of feature-based molecular networking and MassQL for the MS/MS fragmentation study of depsipeptides.Front Mol Biosci. 2023 Aug 1;10:1238475. doi: 10.3389/fmolb.2023.1238475. eCollection 2023. Front Mol Biosci. 2023. PMID: 37593127 Free PMC article.
-
Structural Diversity, Biological Properties and Applications of Natural Products from Cyanobacteria. A Review.Mar Drugs. 2017 Nov 10;15(11):354. doi: 10.3390/md15110354. Mar Drugs. 2017. PMID: 29125580 Free PMC article. Review.
-
Recent Advances in Small Peptides of Marine Origin in Cancer Therapy.Mar Drugs. 2021 Feb 19;19(2):115. doi: 10.3390/md19020115. Mar Drugs. 2021. PMID: 33669851 Free PMC article. Review.
-
Applying a Chemogeographic Strategy for Natural Product Discovery from the Marine Cyanobacterium Moorena bouillonii.Mar Drugs. 2020 Oct 14;18(10):515. doi: 10.3390/md18100515. Mar Drugs. 2020. PMID: 33066480 Free PMC article.
References
-
- Newman DJ, Cragg GM. J Nat Prod. 2016;79:629–661. - PubMed
-
- Newman DJ, Giddings LA. Phytochem Rev. 2014;13:123–137.
-
- Gurib-Fakim A. Mol Asp Med. 2006;27:1–93. - PubMed
-
- Cordell GA, Colvard MD. J Nat Prod. 2012;75:514–525. - PubMed
-
- Williams DH, Stone MJ, Hauck PR, Rahman SK. J Nat Prod. 1989;52:1189–1208. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
